Increasing generic drug use in medicare part D: The role of government

被引：23
作者：
Kohl, Herb
Shrank, William H. [1 ]
机构：
[1] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02120 USA
[2] US Senate, US Senate Special Comm Aging, Washington, DC 20510 USA
来源：
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY | 2007年 / 55卷 / 07期
关键词：
D O I：
10.1111/j.1532-5415.2007.01286.x
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
[No abstract available]
引用
收藏
页码：1106 / 1109
页数：4
相关论文
共 39 条
  • [1] Barriers to patient-physician communication about out-of-pocket costs
    Alexander, GC
    Casalino, LP
    Tseng, CW
    McFadden, D
    Meltzer, DO
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2004, 19 (08) : 856 - 860
  • [2] Patient-physician communication about out-of-pocket costs
    Alexander, GC
    Casalino, LP
    Meltzer, DO
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (07): : 953 - 958
  • [3] Part "D" for "defective" - The Medicare drug benefit chaos.
    Avorn, J
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (13) : 1339 - 1341
  • [4] A RANDOMIZED TRIAL OF A PROGRAM TO REDUCE THE USE OF PSYCHOACTIVE-DRUGS IN NURSING-HOMES
    AVORN, J
    SOUMERAI, SB
    EVERITT, DE
    ROSSDEGNAN, D
    BEERS, MH
    SHERMAN, D
    SALEMSCHATZ, SR
    FIELDS, D
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (03) : 168 - 173
  • [5] *C BUDG OFF, BUDG EC OUTL FISC YE
  • [6] Should patients receive secondary prevention medications for free after a myocardial infarction? An economic analysis
    Choudhry, Niteesh K.
    Avorn, Jerry
    Antman, Elliott M.
    Schneeweiss, Sebastian
    Shrank, William H.
    [J]. HEALTH AFFAIRS, 2007, 26 (01) : 186 - 194
  • [7] COX E, 2006, 2005 GENERIC DRUG US
  • [8] A practical physicians' guide to the medicare drug benefit plan
    Federman, Alex D.
    Alexander, G. Caleb
    Shrank, William H.
    [J]. MAYO CLINIC PROCEEDINGS, 2006, 81 (09) : 1217 - 1221
  • [9] Economic implications of evidence-based prescribing for hypertension - Can better care cost less?
    Fischer, MA
    Avorn, J
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (15): : 1850 - 1856
  • [10] Medicaid prior-authorization programs and the use of cyclooxygenase-2 inhibitors
    Fischer, MA
    Schneeweiss, S
    Avorn, J
    Solomon, DH
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (21) : 2187 - 2194
1234